Archives posted in: Pricing

DaVita Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD February 5, 2026

DaVita, a kidney care provider primarily serving the United States, had a positive FY 2024. Revenue rose 5.6% to $12.8 billion, and…

Nordson Corporation Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD February 5, 2026

Nordson, a precision technology company for dispensing fluids, had a positive FY 2025. Revenue rose 3.8% to $2.8 billion and operating income…

NIKE Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD December 31, 2025

NIKE, an athletic footwear, apparel, and equipment company selling NIKE, Jordan, and Converse brands, had a negative FY 2025. Revenue fell 9.8%…

Allegion Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD December 5, 2025

Allegion, a global provider of branded security products, had a positive FY 2024. Revenue rose 3.3% to $3.8 billion and earnings before…

Quest Diagnostics Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Quest Diagnostics, a U.S. healthcare diagnostic company, had a positive FY 2024. Revenue rose 6.7% to $9.87 billion, and earnings before interest…

Edwards Lifesciences Corporation Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Edwards Lifesciences, a global leader in structural heart innovation, reported a positive FY 2024. Revenue rose 8.6% to $5.4 billion and earnings…

LabCorp Holdings Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

LabCorp, a laboratory services company for medical providers, pharmaceuticals, and researchers, had a positive FY 2024. Revenue rose 7% to $13.0 billion,…

Moderna Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Moderna, a leader in mRNA medicine best known for its COVID vaccine, had a mixed FY 2024. Revenue fell 53% to $3.2…

Where and When is the Inflationary Impact of Tariffs?

By Tim J. Smith, PhD October 1, 2025

Tariffs are in the news, but will they have no to little impact on inflation? What can we expect in the next…

Bristol-Myers Squibb Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Bristol-Myers Squibb, a global biopharmaceutical company, had a mixed FY 2024. Revenue rose 7.3% to $48.3 billion while operating earnings fell 199%…